
新型冠状病毒感染防控期间开展肉毒毒素治疗专家共识
Expert consensus on botulinum toxin treatment practices during coronavirus disease 2019 (COVID-19) prevention and control period
2019冠状病毒病的境内疫情已得到显著改善,但境外确诊病例数及输入病例数均呈上升态势,相关防控措施仍然需要得到重视。肉毒毒素注射是治疗痉挛及肌张力障碍等多种疾病的重要方法,操作过程中会与患者发生近距离接触,存在感染风险。为满足患者在疫情期间接受肉毒毒素注射治疗的需要,指导相关医务人员合理做好防护,特制定此共识,保障医患双方安全。
The domestic epidemic of coronavirus disease 2019 (COVID-19) has been significantly improved, but the number of oversea cases and imported cases is on the rise. Relevant prevention and control measures still need to be paid attention to. Botulinum toxin injection is an important method for the treatment of spasticity, dystonia and other diseases. The operation process requires close contact with the patients and there is a risk of infection. In order to meet the needs of patients receiving botulinum toxin injection during the epidemic period, and to guide relevant medical personnel to make reasonable protection, this consensus is hereby formulated to ensure the safety of both doctors and patients.
2019冠状病毒病 / COVID-19 / 肉毒毒素 / 专家共识
Coronavirus disease 2019
国家重点研发计划(2018YFC1314700);上海市重中之重临床重点学科(2017ZZ02020);上海市市级医疗卫生优秀学科带头人培养计划(2017BR029)
/
〈 |
|
〉 |